|
Would you consider a 47.6% outcome for a study on mood disorders significant? What would you say if this published study was on a micronutrient supplement and not a drug?
Last week, a ground-breaking study published in the British Medical Journal cited that researchers at the University of Canterbury in NZ found the micronutrient supplement Truehope EMPowerplus™ had significant benefits for adults with psychiatric symptoms of ADHD, depression, hyperactivity, impulsivity and inattention. The research publication also identified a major reduction in symptoms in those suffering from ‘moderate’
|
